Herbas VPB

Print
EN | LT
LT - Žmogaus monokloniniai antikūnai prieš sunkaus ūminio respiracinio sindromo koronavirusą 2 (SARS-COV-2)
EN - HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/10 (2006.01)
G01N 33/569 (2006.01)
G01N 33/577 (2006.01)
A61K 39/00 (2006.01)
European patent
(11) Number of the document 4045533
(13) Kind of document T
(96) European patent application number 21719462.0
Date of filing the European patent application 2021-03-25
(97) Date of publication of the European application 2022-08-24
(45) Date of publication and mention of the grant of the patent 2023-11-15
(46) Date of publication of the claims translation 2024-02-26
PCT application
(86) Number PCT/US2021/024215
Date 2021-03-25
PCT application publication
(87) Number WO 2021/195418
Date 2021-09-30
Priority applications
(30) Number Date Country code
202063000299 P 2020-03-26 US
202063002896 P 2020-03-31 US
202063003716 P 2020-04-01 US
202063023545 P 2020-05-12 US
202063024204 P 2020-05-13 US
202063024248 P 2020-05-13 US
202063027173 P 2020-05-19 US
202063037984 P 2020-06-11 US
202063040224 P 2020-06-17 US
202063040246 P 2020-06-17 US
202163142196 P 2021-01-27 US
202163161890 P 2021-03-16 US
Inventors
(72)
CROWE, James E., Jr. , US
ZOST, Seth , US
CARNAHAN, Robert , US
GILCHUK, Pavlo , US
Grantee
(73) Vanderbilt University , 305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, US
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Žmogaus monokloniniai antikūnai prieš sunkaus ūminio respiracinio sindromo koronavirusą 2 (SARS-COV-2)
  HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
Last renewal fee
Payment date Validity (years) Amount
2025-02-18 5 115.00 EUR
Next renewal fee
2026-03-25